Literature DB >> 11376933

Molecular biological approaches to unravel adenylyl cyclase signaling and function.

T B Patel1, Z Du, S Pierre, L Cartin, K Scholich.   

Abstract

Signal transduction through the cell membrane requires the participation of one or more plasma membrane proteins. For many transmembrane signaling events adenylyl cyclases (ACs) are the final effector enzymes which integrate and interpret divergent signals from different pathways. The enzymatic activity of adenylyl cyclases is stimulated or inhibited in response to the activation of a large number of receptors in virtually all cells of the human body. To date, ten different mammalian isoforms of adenylyl cyclase (AC) have been cloned and characterized. Each isoform has its own distinct tissue distribution and regulatory properties, providing possibilities for different cells to respond diversely to similar stimuli. The product of the enzymatic reaction catalyzed by ACs, cyclic AMP (cAMP) has been shown to play a crucial role for a variety of fundamental physiological cell functions ranging from cell growth and differentiation, to transcriptional regulation and apoptosis. In the past, investigations into the regulatory mechanisms of ACs were limited by difficulties associated with their purification and the availability of the proteins in any significant amount. Moreover, nearly every cell expresses several AC isoforms. Therefore, it was difficult to perform biochemical characterization of the different AC isoforms and nearly impossible to assess the physiological roles of the individual isoforms in intact cells, tissue or organisms. Recently, however, different molecular biological approaches have permitted several breakthroughs in the study of ACs. Recombinant technologies have allowed biochemical analysis of adenylyl cyclases in-vitro and the development of transgenic animals as well as knock-out mice have yielded new insights in the physiological role of some AC isoforms. In this review, we will focus mainly on the most novel approaches and concepts, which have delineated the mechanisms regulating AC and unravelled novel functions for this enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376933     DOI: 10.1016/s0378-1119(01)00448-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  51 in total

Review 1.  The many dimensions of cAMP signaling.

Authors:  J H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes.

Authors:  Miriam Erdorf; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-29       Impact factor: 3.000

Review 3.  Choreographing the adenylyl cyclase signalosome: sorting out the partners and the steps.

Authors:  Rennolds S Ostrom; Amy S Bogard; Robert Gros; Ross D Feldman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-10-20       Impact factor: 3.000

4.  Distinct roles of adenylyl cyclase VII in regulating the immune responses in mice.

Authors:  Biyan Duan; Richard Davis; Eva L Sadat; Julie Collins; Paul C Sternweis; Dorothy Yuan; Lily I Jiang
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

5.  Inhibition and superactivation of the calcium-stimulated isoforms of adenylyl cyclase: role of Gbetagamma dimers.

Authors:  Debora Steiner; Tomer Avidor-Reiss; Ester Schallmach; Daniella Saya; Zvi Vogel
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

6.  Regulation of cAMP responses by the G12/13 pathway converges on adenylyl cyclase VII.

Authors:  Lily I Jiang; Julie Collins; Richard Davis; Iain D Fraser; Paul C Sternweis
Journal:  J Biol Chem       Date:  2008-06-09       Impact factor: 5.157

Review 7.  Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP; advantages and pitfalls of differing methodologies.

Authors:  Stephen J Hill; Christine Williams; Lauren T May
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

8.  Dopamine D₄ receptor activation controls circadian timing of the adenylyl cyclase 1/cyclic AMP signaling system in mouse retina.

Authors:  Chad R Jackson; Shyam S Chaurasia; Christopher K Hwang; P Michael Iuvone
Journal:  Eur J Neurosci       Date:  2011-06-16       Impact factor: 3.386

9.  Pharmacological distinction between soluble and transmembrane adenylyl cyclases.

Authors:  Jacob L Bitterman; Lavoisier Ramos-Espiritu; Ana Diaz; Lonny R Levin; Jochen Buck
Journal:  J Pharmacol Exp Ther       Date:  2013-10-03       Impact factor: 4.030

10.  PAM mediates sustained inhibition of cAMP signaling by sphingosine-1-phosphate.

Authors:  Sandra C Pierre; Julia Häusler; Kerstin Birod; Gerd Geisslinger; Klaus Scholich
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.